Skip Nav Destination
Close Modal
Update search
NARROW
Format
Journal
Date
Availability
1-2 of 2
Virginie Callot
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Publisher: Journals Gateway
Imaging Neuroscience (2025) 3: imag_a_00559.
Published: 07 May 2025
FIGURES
| View All (7)
Abstract
View articletitled, Body size and intracranial volume interact with the structure of the central nervous system: A multi-center in vivo neuroimaging study
View
PDF
for article titled, Body size and intracranial volume interact with the structure of the central nervous system: A multi-center in vivo neuroimaging study
Clinical research emphasizes the implementation of rigorous and reproducible study designs that rely on between-group matching or controlling for sources of biological variation such as subject’s sex and age. However, corrections for body size (i.e., height and weight) are mostly lacking in clinical neuroimaging designs. This study investigates the importance of body size parameters in their relationship with spinal cord (SC) and brain magnetic resonance imaging (MRI) metrics. Data were derived from a cosmopolitan population of 267 healthy human adults (age 30.1 ± 6.6 years old, 125 females). We show that body height correlates with brain gray matter (GM) volume, cortical GM volume, total cerebellar volume, brainstem volume, and cross-sectional area (CSA) of cervical SC white matter (CSA-WM; 0.44 ≤ r ≤ 0.62). Intracranial volume (ICV) correlates with body height (r = 0.46) and the brain volumes and CSA-WM (0.37 ≤ r ≤ 0.77). In comparison, age correlates with cortical GM volume, precentral GM volume, and cortical thickness (-0.21 ≥ r ≥ -0.27). Body weight correlates with magnetization transfer ratio in the SC WM, dorsal columns, and lateral corticospinal tracts (-0.20 ≥ r ≥ -0.23). Body weight further correlates with the mean diffusivity derived from diffusion tensor imaging (DTI) in SC WM (r = -0.20) and dorsal columns (-0.21), but only in males. CSA-WM correlates with brain volumes (0.39 ≤ r ≤ 0.64), and with precentral gyrus thickness and DTI-based fractional anisotropy in SC dorsal columns and SC lateral corticospinal tracts (-0.22 ≥ r ≥ -0.25). Linear mixture of age, sex, or sex and age, explained 2 ± 2%, 24 ± 10%, or 26 ± 10%, of data variance in brain volumetry and SC CSA. The amount of explained variance increased to 33 ± 11%, 41 ± 17%, or 46 ± 17%, when body height, ICV, or body height and ICV were added into the mixture model. In females, the explained variances halved suggesting another unidentified biological factor(s) determining females’ central nervous system (CNS) morphology. In conclusion, body size and ICV are significant biological variables. Along with sex and age, body size should therefore be included as a mandatory variable in the design of clinical neuroimaging studies examining SC and brain structure; and body size and ICV should be considered as covariates in statistical analyses. Normalization of different brain regions with ICV diminishes their correlations with body size, but simultaneously amplifies ICV-related variance (r = 0.72 ± 0.07) and suppresses volume variance of the different brain regions (r = 0.12 ± 0.19) in the normalized measurements.
Includes: Supplementary data
Journal Articles
Test-retest repeatability of intravoxel incoherent motion (IVIM) measurements in the cervical cord
Open AccessPublisher: Journals Gateway
Imaging Neuroscience (2025) 3: imag_a_00468.
Published: 10 February 2025
FIGURES
| View All (6)
Abstract
View articletitled, Test-retest repeatability of intravoxel incoherent motion (IVIM) measurements in the cervical cord
View
PDF
for article titled, Test-retest repeatability of intravoxel incoherent motion (IVIM) measurements in the cervical cord
Intravoxel incoherent motion (IVIM) measurements allow to probe tissue microcirculation non-invasively. Spinal cord perfusion has been shown to be altered following different neurological pathologies. A non-invasive imaging protocol to assess perfusion in the cervical cord is, therefore, clinically relevant. This work aimed at assessing the reliability of IVIM parameters sensitive to perfusion changes in the cervical cord by determining the test-retest variability across subjects and different post-processing fitting algorithms. IVIM test-retest scans were acquired in the cervical cord (C1-C3) of 10 healthy subjects on a 3T MRI scanner, with a 15-minute break in-between. IVIM parameters, including microvascular volume fraction ( F ), pseudo-diffusion coefficient ( D * ), blood flow-related coefficient ( F · D * ), and diffusion coefficient ( D ), were derived using voxel-wise and region of interest (ROI)-wise fits. The reliability of each IVIM parameter was determined with coefficients of variation (CV), intraclass correlation coefficients (ICC), Bland-Altman analysis, and linear regression. To assess the effects of the different fitting approaches, a two-way repeated-measures analysis of variance (ANOVA) was conducted on the CVs calculated across fitting algorithms. Mean CVs of IVIM parameters calculated across subjects using the voxel-wise fit were lower in the white matter (WM) and grey matter (GM): (WM: 2.6% to 15.6%; GM: 2.2% to 16.4%) compared with those calculated using the ROI-wise fit approach (WM: 4.5% to 32.2%; GM: 3.4% to 53.4%). The voxel-wise fit in the WM yielded higher ICC values (good-to-excellent, 0.71–0.97) compared to the ROI-wise fit approach (poor-to-excellent, 0.49–0.90). IVIM parameters, derived using the voxel-wise fitting approach, demonstrated a high reliability in the cervical cord. Results highlight the high variability of IVIM parameter values depending on the fitting approach, underlining the importance of characterizing the reliability of IVIM acquisition and fitting configuration in the relevant organ of interest. Robust IVIM metrics using a voxel-wise one-step approach, observed across scans and subjects, can facilitate studies targeting perfusion impairment and pave the way to future clinical trials assessing perfusion impairment as a potential quantitative biomarker.
Includes: Supplementary data